Raju Kandimalla
Raju Kandimalla
Bristol-Myers Squibb
Verified email at celgene.com
Title
Cited by
Cited by
Year
DNA methylation-based biomarkers in bladder cancer
R Kandimalla, AA Van Tilborg, EC Zwarthoff
Nature Reviews Urology 10 (6), 327, 2013
1142013
Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers
R Kandimalla, AAG van Tilborg, LC Kompier, DJPM Stumpel, RW Stam, ...
European urology 61 (6), 1245-1256, 2012
1142012
DNA methylation based biomarkers in colorectal cancer: A systematic review
K Lam, K Pan, JF Linnekamp, JP Medema, R Kandimalla
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1866 (1), 106-120, 2016
802016
A 3-plex methylation assay combined with the FGFR3 mutation assay sensitively detects recurrent bladder cancer in voided urine
R Kandimalla, R Masius, W Beukers, CH Bangma, TF Orntoft, L Dyrskjot, ...
Clinical cancer research 19 (17), 4760-4769, 2013
602013
Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models
JF Linnekamp, SR van Hooff, PR Prasetyanti, R Kandimalla, ...
Cell Death & Differentiation 25 (3), 616-633, 2018
542018
FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study
W Beukers, KA van der Keur, R Kandimalla, Y Vergouwe, EW Steyerberg, ...
The Journal of urology 197 (6), 1410-1418, 2017
442017
Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer
W Beukers, R Kandimalla, RG Masius, M Vermeij, R Kranse, ...
Modern Pathology 28 (4), 515-522, 2015
392015
Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities
W Wang, R Kandimalla, H Huang, L Zhu, Y Li, F Gao, A Goel, X Wang
Seminars in cancer biology 55, 37-52, 2019
322019
A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype
E Fessler, M Jansen, FDSE Melo, L Zhao, PR Prasetyanti, H Rodermond, ...
Oncogene 35 (46), 6026-6037, 2016
322016
Relationship between genome and epigenome-challenges and requirements for future research
G Almouzni, L Altucci, B Amati, N Ashley, D Baulcombe, N Beaujean, ...
BMC genomics 15 (1), 487, 2014
272014
A microRNA signature associated with metastasis of T1 colorectal cancers to lymph nodes
T Ozawa, R Kandimalla, F Gao, H Nozawa, K Hata, H Nagata, S Okada, ...
Gastroenterology 154 (4), 844-848. e7, 2018
262018
Hypermethylation of the Polycomb Group Target Gene PCDH7 in Bladder Tumors from Patients of All Ages
W Beukers, A Hercegovac, M Vermeij, R Kandimalla, AC Blok, ...
The Journal of urology 190 (1), 311-316, 2013
242013
Minicircle and miniplasmid dna vectors: the future of non-viral and viral gene transfer
M Schleef
John Wiley & Sons, 2013
212013
ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis
S Di Franco, A Turdo, A Benfante, ML Colorito, M Gaggianesi, T Apuzzo, ...
Oncotarget 7 (34), 54157, 2016
192016
Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer
R Kandimalla, JF Linnekamp, S Van Hooff, A Castells, X Llor, M Andreu, ...
Oncogenesis 6 (4), e308-e308, 2017
182017
The use of molecular analyses in voided urine for the assessment of patients with hematuria
W Beukers, R Kandimalla, D van Houwelingen, H Kovacic, JFD Chin, ...
PloS one 8 (10), e77657, 2013
182013
GALR1 methylation in vaginal swabs is highly accurate in identifying women with endometrial cancer
K Doufekas, R Hadwin, R Kandimalla, A Jones, T Mould, S Crowe, ...
International Journal of Gynecologic Cancer 23 (6), 2013
172013
Genome-wide discovery and identification of a novel miRNA signature for recurrence prediction in stage II and III colorectal cancer
R Kandimalla, F Gao, T Matsuyama, T Ishikawa, H Uetake, N Takahashi, ...
Clinical Cancer Research 24 (16), 3867-3877, 2018
162018
Intratumoral Fusobacterium nucleatum levels predict therapeutic response to neoadjuvant chemotherapy in esophageal squamous cell carcinoma
K Yamamura, D Izumi, R Kandimalla, F Sonohara, Y Baba, N Yoshida, ...
Clinical Cancer Research 25 (20), 6170-6179, 2019
82019
Replicating Minicircles: Overcoming the limitations of transient and of stable expression systems
K Nehlsen, S Broll, R Kandimalla, N Heinz, M Heine, S Binius, ...
Minicircle and Plasmid DNA Vectors–The Future of Non-Viral and Viral Gene …, 2012
62012
The system can't perform the operation now. Try again later.
Articles 1–20